CJ

Chandrakanta Jayantilal Sancheti

Director Additional Director DIN 07294110
DIN 07294110 First appointment Sep 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Sep 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandrakanta Jayantilal Sancheti

Data last updated:

Chandrakanta Jayantilal Sancheti was an Additional Director at Magine Pharmaceuticals Private Limited (2015–2016). The company operates in Pharma.

DIN 07294110
Primary Designation Additional Director
Industry Pharma
First Appointment 19 Sep 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director19 Sep 20152011₹1.40 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Magine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandrakanta Jayantilal Sancheti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrakanta Jayantilal Sancheti

Chandrakanta Jayantilal Sancheti was first appointed on 19 Sep 2015 as Additional Director at Magine Pharmaceuticals Private Limited.

Chandrakanta Jayantilal Sancheti held 1 earlier board appointment: Magine Pharmaceuticals Private Limited (Additional Director, 19 Sep 2015 to 14 Mar 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available